Quotient Biodiagnostics

About:

Quotient Biodiagnostics develops and manufactures products for use in transfusion diagnostics.

Top Investors: MidCap Financial, Highbridge Capital Management, Galen Partners, Paul Cowan

Description:

Quotient Biodiagnostics is focused on providing high quality, high value immunohematology products to hospitals and blood banks in the US. Through its wholly-owned subsidiary, Alba Bioscience, Quotient offers more than 30 years of research, development and manufacturing of transfusion diagnostics products that traditionally have been sold worldwide either directly or by other major transfusion companies.

Total Funding Amount:

$424M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Newtown, Pennsylvania, United States

Founded Date:

2008-01-01

Contact Email:

customer.service(AT)QuotientBD.com

Founders:

Paul Cowan